Kevin Mange M.D., Msce

Kevin Mange, MD, MSCE has an extensive work experience in the healthcare and pharmaceutical industry. Kevin is currently serving as the Chief Development Officer at Insmed Incorporated since January 2023. Prior to this, they held the position of Senior Vice President and Head of Clinical Development at Insmed Incorporated from December 2019 to January 2023. In this role, they were responsible for the development of new investigational agents for rare diseases. Before joining Insmed Incorporated, Dr. Mange worked at Sanofi as the Global Project Head and Vice President for Rare Diseases from May 2017 to July 2018. Kevin also served as the Vice President and Medical Unit Head for Immunology and Inflammation in North America at Sanofi from September 2014 to May 2017. Earlier in their career, they held positions at Barnabas Health as the Vice President and Chief Medical Officer and at Novartis as the Vice President in clinical development and medical affairs. Kevin has also worked at the Hospital of the University of Pennsylvania and Beth Israel Deaconess Medical Center/Harvard Medical School. Dr. Mange's work experience spans various therapeutic areas and they have extensive experience in clinical development, medical affairs, and leadership roles.

Kevin Mange, MD, MSCE, has an extensive education history. Kevin began their educational journey at Ursinus College, where they pursued a Bachelor of Science degree, with honors in Chemistry. Kevin completed their undergraduate studies in 1988.

Afterwards, Kevin attended Thomas Jefferson University from 1988 to 1992, obtaining their Medical Doctorate (MD) in the field of Medicine.

Seeking further specialization, Kevin pursued Clinical Epidemiology and enrolled in the University of Pennsylvania School of Medicine from 1997 to 1999. Kevin successfully completed their Master of Science in Clinical Epidemiology (MSCE) during this time.

In addition to their educational achievements, Kevin has further obtained certifications in the medical field. Kevin is board-certified in both Nephrology and Internal Medicine by the American Board of Internal Medicine. However, specific dates of when they acquired these certifications are not provided.